Evidence map›Paper›PMID 35589150›Full record

ArticleBMJ global health2022

Taking stock of global commitments on antimicrobial resistance.

Serena Tejpar, Susan Rogers Van Katwyk, Lindsay Wilson, Steven J Hoffman

Abstract read
In one paragraph

Article in BMJ global health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Antimicrobial Susceptibility Profiles ofVeterinary sciences · 2024
    Article
  10. Article
  11. Article
  12. Review
  13. Adopting a Global AMR Target within the Pandemic Instrument Will Act as a Catalyst for Action.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Serena TejparGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health, York University, Toronto, Ontario, Canada.ORCID 0000-0001-6709-1638
Susan Rogers Van KatwykGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health, York University, Toronto, Ontario, Canada.ORCID 0000-0002-1758-8635
Lindsay WilsonGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health, York University, Toronto, Ontario, Canada.ORCID 0000-0002-9910-3338
Steven J HoffmanGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, School of Global Health, York University, Toronto, Ontario, Canada steven.hoffman@globalstrategylab.org.ORCID 0000-0002-2064-3711

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over the last six years, antimicrobial resistance (AMR) has generated an unprecedented amount of global attention. This global attention has coincided with an increase in discussion around AMR at various multilateral organisations and international fora. This study catalogues and analyses AMR-related commitments made by the global community following the implementation of the AMR Tripartite's Global Action Plan (GAP) in 2015. In examining these commitments, we elucidated emergent themes and gaps in AMR discourse through a qualitative content analysis of global political resolutions, declarations and statements made by members of the United Nations, the World Health Assembly, Food and Agriculture Organization Conferences, World Organisation for Animal Health General Sessions, and the G7 and G20 summits and ministerial meetings between the years 2015 and 2021. Emergent themes included AMR research, surveillance and stewardship. Across sectors, fewer commitments were made for specific action on AMR in the environment. The themes and types of commitments were found to be consistent across time and fora but did not evolve into more concrete or nuanced pledges to action between 2015 and 2021. GAP objectives relating to infection prevention and efforts to address the root drivers of AMR appeared the least frequently in our analysis, indicating a lack of global commitment to take a proactive prevention-focused approach to AMR.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialAnimalsGlobal HealthHumansUnited NationsAnti-Bacterial AgentsAntimicrobial ResistanceDrug Resistant InfectionsFood and AgricultureOrganisationG7 G20Global GovernanceGlobal HealthUnited NationsWHOWorldOrganisationfor Animal Health

Identifiers

PMID35589150
PMCPMC9121412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.